	La Marge Brute Sur Les Ventes		Date
AbbVie	USD 10.47B	605M	2025-09
Abbott	USD 6.54B	625M	2025-12
Amgen	USD 6.48B	307M	2025-09
AstraZeneca	USD 12.39B	406M	2025-09
Baxter International	USD 950M	194M	2025-09
Bayer	EUR 5.35B	1.02B	2025-09
Becton, Dickinson and Co.	USD 696M	1.94B	2025-09
Biogen	USD 1.65B	34.6M	2025-12
Boston Scientific	USD 3.68B	136M	2025-12
Bristol-Myers Squibb	USD 8.79B	110M	2025-09
CONMED	USD 218.29M	52.17M	2025-12
Cooper Companies	USD 650.8M	62.6M	2025-09
Dexcom	USD 688.8M	99.8M	2025-06
Edwards Lifesciences	USD 1.19B	76.7M	2025-06
Eli Lilly	USD 14.59B	1.48B	2025-09
Gilead Sciences	USD 5.58B	453M	2025-06
GlaxoSmithKline	GBP 6.18B	106M	2025-12
Globus Medical	USD 486.67M	725.06M	2025-09
Hologic	USD 586.4M	2.9M	2025-12
Insulet	USD 510.1M	57.9M	2025-09
Integra LifeSciences	USD 206.99M	2.34M	2025-09
Intuitive Surgical	USD 1.9B	241.9M	2025-12
J&J	USD 16.6B	118M	2025-12
Medtronic	USD 5.44B	123M	2025-09
Merck	USD 13.42B	431M	2025-09
Merit Medical Systems	USD 184.49M	12.47M	2025-06
Novartis	USD 10.82B	695M	2025-09
Pfizer	USD 3.54B	7.61B	2025-09
Regeneron Pharmaceuticals	USD 3.3B	67M	2025-12
Roche Holding	CHF 22.09B	10.04B	2025-12
Sanofi	EUR 8.45B	1.31B	2025-12
Stryker	USD 4.49B	633M	2025-12
Tandem Diabetes Care	USD 134.29M	8.44M	2025-09
Teva Pharmaceutical Industries	USD 2.66B	351M	2025-12
Vertex Pharmaceuticals	USD 2.66B	104.4M	2025-09
Zimmer Biomet Holdings	USD 1.27B	58.9M	2025-09
Zoetis	USD 1.72B	96M	2025-09

J&J La Marge Brute Sur Les Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.